Quetiapine extended release: A guide to its use as adjunctive treatment in major depressive disorder

被引：0

作者：

Gillian M. Keating

Mark Sanford

机构：

[1] Adis, North Shore 0754, Auckland, 41 Centorian Drive, Mairangi Bay

来源：

Drugs & Therapy Perspectives | 2012年 / 28卷 / 3期

关键词：

Adis-Clinical-Q-and-A; Major-depressive-disorder; Quetiapine;

D O I：

10.2165/11209210-000000000-00000

中图分类号：

学科分类号：

摘要：

Once-daily oral quetiapine extended release (XR) is effective as an adjunct to antidepressant therapy in the treatment of patients with a major depressive episode and an inadequate response to an antidepressant alone. The tolerability profile of quetiapine XR when administered as adjunctive therapy in patients with major depressive disorder is consistent with that seen in other indications. © 2012 Adis Data Information BV. All rights reserved.

引用

页码：7 / 11

页数：4

共 18 条

[1]

The global burden of disease: 2004 update, World Health Organization, (2008)

[2]

Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S., The Epidemiology of Major Depressive Disorder: Results from the National Comorbidity Survey Replication (NCS-R), Journal of the American Medical Association, 289, 23, pp. 3095-3105, (2003)

[3]

Janicak P.G., Dowd S.M., Treatment-resistant depression: An update on diagnosis and management, Psychopharm. Rev., 44, 6, pp. 41-48, (2009)

[4]

Mann J.J., The medical management of depression, N. Engl. J. Med., 353, 17, pp. 1819-1834, (2005)

[5]

Davidson J.R.T., Major depressive disorder treatment guidelines in america and europe, J. Clin. Psychiatry, 71, E1, (2010)

[6]

Sanford M., Quetiapine extended release: Adjunctive treatment in major depressive disorder, CNS Drugs, 25, 9, pp. 803-813, (2011)

[7]

Questions and answers on seroquel XR and associated names 50 150 200 300 and 400mg prolonged-release tablets containing quetiapine: Outcome of a procedure under article 6 13 of regulation EC 1084 2003 as amended, London: European Medicines Agency, (2010)

[8]

Seroquel X.L., Quetiapine extended release 50 mg 150 mg 200 mg 300 mg 400 mg prolonged-release tablets: Summary of product characteristics, Luton: AstraZeneca UK Limited, (2011)

[9]

Seroquel X.R., Quetiapine fumarate tablets: US prescribing information, Wilmington DE: AstraZeneca, (2011)

[10]

Seroquel S.R., Prolonged release tablets: Summary of product characteristics in portuguese, Barcarena: Astra Zeneca Pharmaceuticals, (2011)

← 1 2 →